The experimental data described above demonstrated the tumor suppressive function of EFEMP1, which operates by attenuating and blocking EGF-stimulated EGFR signaling activities, and is consistent with the patient outcomes predicted based on the EGFR level in the subset of gliomas expressing a low level of EFEMP1 (Figure 6A). The gene discussed is EGFR; the disease is central nervous system cancer.